Menlo Therapeutics Inc.·4/A

Aug 7, 7:27 PM ET

BALL KRISTINE M 4/A

4/A · Menlo Therapeutics Inc. · Filed Aug 7, 2019

Insider Transaction Report

Form 4/AAmended
Period: 2019-07-29
BALL KRISTINE M
SVP, Corporate Strategy & CFO
Transactions
  • Award

    Restricted Stock Units

    2019-07-29+80,300413,423 total
    Common Stock (80,300 underlying)
Footnotes (3)
  • [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive a share of the Issuer's common stock.
  • [F2]The RSUs shall vest in two (2) equal annual installments beginning July 29, 2020, provided Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissable Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.
  • [F3]Not Applicable

Documents

2 files